Lineage Cell Therapeutics (LCTX) EBITDA (2010 - 2026)
Lineage Cell Therapeutics posted quarterly EBITDA of -$7.6 million for Q1 2026, down 16.73% year-on-year from -$9.1 million in Q1 2025, and down 148.14% on a QoQ basis from $15.8 million in Q4 2025.
Lineage Cell Therapeutics (LCTX) has 17 years of EBITDA data on file, last reported at -$7.6 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 16.73% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$15.4 million (up 27.84% YoY), and the FY2025 full-year result was -$14.3 million, up 33.43% from the prior year.
- EBITDA for Q1 2026 stood at -$7.6 million, down from $15.8 million in the prior quarter.
- Across five years, EBITDA topped out at $15.8 million in Q4 2025 and bottomed at -$19.8 million in Q2 2025.
- The 5-year median for EBITDA is -$6.4 million (2023), against an average of -$5.3 million.
- Peak annual rise in EBITDA reached 408.69% in 2025, while the deepest fall reached 237.14% in 2025.
- A 5-year view of EBITDA shows it stood at -$6.6 million in 2022, then rose by 4.17% to -$6.4 million in 2023, then grew by 19.68% to -$5.1 million in 2024, then jumped by 408.69% to $15.8 million in 2025, then sank by 148.14% to -$7.6 million in 2026.
- The last three EBITDA figures came in at -$7.6 million (Q1 2026), $15.8 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Lineage Cell Therapeutics | 325.89 Mn | 261.99 Mn | 1.73 Mn | -7.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.59 Mn |
| Dec 31, 2025 | 15.77 Mn |
| Sep 30, 2025 | -3.79 Mn |
| Jun 30, 2025 | -19.78 Mn |
| Mar 31, 2025 | -6.51 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Jun 30, 2024 | -5.87 Mn |
| Mar 31, 2024 | -6.66 Mn |
| Dec 31, 2023 | -6.36 Mn |
| Sep 30, 2023 | -6.71 Mn |
| Jun 30, 2023 | -5.02 Mn |
| Mar 31, 2023 | -6.64 Mn |
| Dec 31, 2022 | -6.64 Mn |
| Sep 30, 2022 | -5.25 Mn |
| Jun 30, 2022 | -4.23 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -28.24 Mn |
| Sep 30, 2021 | -6.84 Mn |
| Jun 30, 2021 | -7.08 Mn |
| Mar 31, 2021 | -7.05 Mn |
| Dec 31, 2020 | -5.88 Mn |
| Sep 30, 2020 | -6.73 Mn |
| Jun 30, 2020 | -6.40 Mn |
| Mar 31, 2020 | -7.44 Mn |
| Dec 31, 2019 | -6.87 Mn |
| Sep 30, 2019 | -8.42 Mn |
| Jun 30, 2019 | -10.82 Mn |
| Mar 31, 2019 | -12.76 Mn |
| Dec 31, 2018 | -10.11 Mn |
| Sep 30, 2018 | -10.36 Mn |
| Jun 30, 2018 | -9.14 Mn |
| Mar 31, 2018 | -12.19 Mn |
| Dec 31, 2017 | -9.56 Mn |
| Sep 30, 2017 | -9.51 Mn |
| Jun 30, 2017 | -8.56 Mn |
| Mar 31, 2017 | -11.26 Mn |
| Dec 31, 2016 | -11.25 Mn |
| Sep 30, 2016 | -9.56 Mn |
| Jun 30, 2016 | -14.40 Mn |
| Mar 31, 2016 | -23.76 Mn |
| Dec 31, 2015 | -21.71 Mn |
| Sep 30, 2015 | -17.10 Mn |
| Jun 30, 2015 | -13.50 Mn |
| Mar 31, 2015 | -13.50 Mn |
| Dec 31, 2014 | -14.41 Mn |
| Sep 30, 2014 | -8.34 Mn |
| Jun 30, 2014 | -9.59 Mn |
| Mar 31, 2014 | -8.21 Mn |
| Dec 31, 2013 | -19.67 Mn |
| Sep 30, 2013 | -9.00 Mn |
| Jun 30, 2013 | -7.52 Mn |
| Mar 31, 2013 | -7.57 Mn |
| Dec 31, 2012 | -5.90 Mn |
| Sep 30, 2012 | -4.97 Mn |
| Jun 30, 2012 | -5.64 Mn |
| Mar 31, 2012 | -4.85 Mn |
| Dec 31, 2011 | -5.48 Mn |
| Sep 30, 2011 | -3.04 Mn |
| Jun 30, 2011 | -5.21 Mn |
| Mar 31, 2011 | -4.03 Mn |
| Dec 31, 2010 | -2.07 Mn |
| Sep 30, 2010 | -4.67 Mn |